Your browser doesn't support javascript.
loading
Interferon beta increases c-Myc proteolysis in mouse monocyte/macrophage leukemia cells.
Hu, Xinrong; Bies, Juraj; Wolff, Linda.
Afiliación
  • Hu X; Leukemogenesis Section, Laboratory of Cellular Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892-4255, USA.
Leuk Res ; 29(11): 1307-14, 2005 Nov.
Article en En | MEDLINE | ID: mdl-15939469
ABSTRACT
Growth inhibitory activity of interferons (IFNs) has been attributed to several events. These include rapid induction of cyclin-dependent kinase inhibitors, such as those in the Cip/Kip and Ink 4 families and down-regulation of c-myc mRNA and c-Myc transcriptional activity. Here, we report an additional mechanism, involving regulation of Myc protein levels, through which type 1 IFN may halt proliferation of cells. This was discovered using a cell line which constitutively expresses c-myc from a retrovirus vector and which was reported to have undergone deletion of genes encoding the Ink 4 tumor suppressors p15 and p16. IFNbeta caused a reduction in the steady state level of c-Myc protein by increasing degradation through the 26S proteasome. Our data, as well as that of others, indicate that multiple levels of c-Myc expression can be affected by IFN treatment and this contributes to rapid growth arrest in the G1 phase of the cell cycle.
Asunto(s)
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas c-myc / Interferón beta Límite: Animals Idioma: En Revista: Leuk Res Año: 2005 Tipo del documento: Article País de afiliación: Estados Unidos
Buscar en Google
Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Proteínas Proto-Oncogénicas c-myc / Interferón beta Límite: Animals Idioma: En Revista: Leuk Res Año: 2005 Tipo del documento: Article País de afiliación: Estados Unidos